- Home
- ATYR vs TTI Comparison
ATYR vs TTI Comparison
Compare ATYR & TTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATYR
- TTI
- Stock Information
- Founded
- ATYR 2005
- TTI 1981
- Country
- ATYR United States
- TTI United States
- Employees
- ATYR N/A
- TTI N/A
- Industry
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- TTI Oil & Gas Production
- Sector
- ATYR Health Care
- TTI Energy
- Exchange
- ATYR Nasdaq
- TTI Nasdaq
- Market Cap
- ATYR 451.3M
- TTI 508.3M
- IPO Year
- ATYR 2015
- TTI 1990
- Fundamental
- Price
- ATYR $4.70
- TTI $3.87
- Analyst Decision
- ATYR Strong Buy
- TTI Strong Buy
- Analyst Count
- ATYR 6
- TTI 2
- Target Price
- ATYR $20.20
- TTI $5.75
- AVG Volume (30 Days)
- ATYR 6.0M
- TTI 1.7M
- Earning Date
- ATYR 08-12-2025
- TTI 07-29-2025
- Dividend Yield
- ATYR N/A
- TTI N/A
- EPS Growth
- ATYR N/A
- TTI 1057.83
- EPS
- ATYR N/A
- TTI 0.86
- Revenue
- ATYR N/A
- TTI $607,216,000.00
- Revenue This Year
- ATYR $551.06
- TTI $1.70
- Revenue Next Year
- ATYR $1,874.58
- TTI $5.17
- P/E Ratio
- ATYR N/A
- TTI $4.31
- Revenue Growth
- ATYR N/A
- TTI N/A
- 52 Week Low
- ATYR $1.67
- TTI $2.03
- 52 Week High
- ATYR $7.29
- TTI $5.12
- Technical
- Relative Strength Index (RSI)
- ATYR 42.54
- TTI 60.26
- Support Level
- ATYR $5.46
- TTI $3.64
- Resistance Level
- ATYR $7.29
- TTI $4.54
- Average True Range (ATR)
- ATYR 0.65
- TTI 0.22
- MACD
- ATYR -0.16
- TTI 0.04
- Stochastic Oscillator
- ATYR 8.32
- TTI 51.09
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can cause to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.
About TTI Tetra Technologies Inc.
Tetra Technologies Inc is a diversified oil and gas services company, focused on completion fluids and associated products and services, water management, frac flowback, production well testing, offshore rig cooling, and compression services. It has two reporting segments namely Completion Fluids & Products, and Water & Flowback Services. The Completion Fluids & Products Division manufactures and markets clear brine fluids, additives, and associated products and services. Majority of revenue is from Completion Fluids & Products. The company derives maximum revenue from United states.